Meeting NewsVideo

VIDEO: Bimatoprost SR shows long-term IOP lowering

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, E. Randy Craven, MD, discusses a study looking at the long-term IOP-lowering effects of Bimatoprost SR (Allergan) in patients with glaucoma.

SAN DIEGO — At the American Society of Cataract and Refractive Surgery meeting, E. Randy Craven, MD, discusses a study looking at the long-term IOP-lowering effects of Bimatoprost SR (Allergan) in patients with glaucoma.

    See more from American Society of Cataract and Refractive Surgery Meeting